ArticleJournal of nanobiotechnology2026
A NIR-IIb-excited capsule endoscope enabling high-contrast fluorescence imaging via spectrally-isolated detection for early-stage gastrointestinal cancer.
Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Early detection of gastrointestinal cancers faces significant challenges, mainly including the invasiveness of wired endoscopes, the limited tissue penetration depth of white light capsule endoscopy (CE), and the low signal-to-noise ratio (SNR) and contrast caused by excitation light interference in traditional fluorescence imaging CE. Herein, we developed a near-infrared-IIb (NIR-IIb) window-excited fluorescence imaging capsule endoscope (FICE) for the high-contrast diagnosis of early-stage gastrointestinal cancers. The FICE employs a 1550-nm central wavelength NIR-IIb laser diode to precisely shape the excitation beam for selective activation of upconversion nanoprobes (UCNPs) aggregates in lesion tissues, stimulating them to emit 540 nm green fluorescence-the most sensitive wavelength for CMOS imaging chips. Utilizing 1550 nm excitation light facilitates enhanced penetration into biological tissues and the detection method with an excitation-emission spectral separation of more than 1000 nm effectively eliminates background interference, thereby yielding diagnostic images with ultrahigh SNR and superior contrast. Proof-of-concept experiments in nude mice demonstrated that this FICE achieved specific fluorescence detection of subcutaneous and colonic mucosal tumors with a penetration depth of up to 6 mm and fluorescence-to-background contrast ratios exceeding 90%. Ex vivo validation in porcine tissues confirmed the FICE's imaging capability within realistic anatomical environments. Furthermore, we designed a wireless power supply and posture control system to provide continuous energy and precise motion control for the FICE. To our knowledge, this paper presents the first NIR-IIb-excited FICE, offering a non-invasive, high-contrast and high-SNR diagnostic tool for early gastrointestinal cancer detection and demonstrating remarkable clinical potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.